See every side of every news story
Published loading...Updated

Annovis Bio to Host Patient-Centered Webcast on Key Clinical Developments

Summary by MyChesCo
MALVERN, PA — Annovis Bio, Inc. (NYSE: ANVS) will hold a live webcast aimed at providing patients, caregivers, and families with updates on its clinical trials and future plans. The virtual event, titled Annovis Patients’ Forum: Your Questions Answered, is scheduled for February 27, 2025, at 4:30 PM EST. The webcast will feature CEO Maria Maccecchini, Ph.D., who will share insights into the company’s ongoing Phase 3 Alzheimer’s disease (AD) tria…
DisclaimerThis story is only covered by news sources that have yet to be evaluated by the independent media monitoring agencies we use to assess the quality and reliability of news outlets on our platform. Learn more here.

1 Articles

All
Left
Center
Right
Think freely.Subscribe and get full access to Ground NewsSubscriptions start at $9.99/yearSubscribe

Bias Distribution

  • There is no tracked Bias information for the sources covering this story.
Factuality

To view factuality data please Upgrade to Premium

Ownership

To view ownership data please Upgrade to Vantage

MyChesCo broke the news in on Thursday, February 20, 2025.
Sources are mostly out of (0)